Purple Biotech Ltd ADR [NASDAQ: PPBT] plunged by -$0.13 during the normal trading session on Thursday and reaching a high of $2.73 during the day while it closed the day at $2.62.
Purple Biotech Ltd ADR stock has also gained 3.56% of its value over the past 7 days. However, PPBT stock has declined by -1.96% in the 3 months of the year. Over the past six months meanwhile, it has lost -24.28% and lost -62.68% year-on date.
The market cap for PPBT stock reached $7.44 million, with 2.84 million shares outstanding and 2.84 million shares in the current float. Compared to the average trading volume of 110.05K shares, PPBT reached a trading volume of 4484068 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Purple Biotech Ltd ADR [PPBT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PPBT shares is $34.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PPBT stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 0.21, with the Price to Cash per share for the same quarter was set at 2.50.
PPBT stock trade performance evaluation
Purple Biotech Ltd ADR [PPBT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 3.56. With this latest performance, PPBT shares gained by 12.93% in over the last four-week period, additionally sinking by -24.28% over the last 6 months – not to mention a drop of -44.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PPBT stock in for the last two-week period is set at 55.57, with the RSI for the last a single of trading hit 0.17, and the three-weeks RSI is set at 0.16 for Purple Biotech Ltd ADR [PPBT]. The present Moving Average for the last 50 days of trading for this stock 2.47, while it was recorded at 2.69 for the last single week of trading, and 3.09 for the last 200 days.
Purple Biotech Ltd ADR (PPBT) Capital Structure & Debt Analysis
According to recent financial data for Purple Biotech Ltd ADR. ( PPBT), the Return on Equity (ROE) stands at -12.35%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -10.42%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Purple Biotech Ltd ADR’s Return on Invested Capital (ROIC) is -12.04%, showcasing its effectiveness in deploying capital for earnings.
Purple Biotech Ltd ADR (PPBT) Efficiency & Liquidity Metrics
Based on Purple Biotech Ltd ADR’s (PPBT) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Purple Biotech Ltd ADR (PPBT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Purple Biotech Ltd ADR. (PPBT) effectively leverages its workforce, generating an average of -$436666.67 per employee. The company’s liquidity position is robust, with a Current Ratio of 2.72% and a Quick Ratio of 2.72%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for Purple Biotech Ltd ADR [PPBT] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PPBT. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Purple Biotech Ltd ADR go to 50.64%.
Purple Biotech Ltd ADR [PPBT]: Institutional Ownership
There are presently around $1.94%, or 1.94% of PPBT stock, in the hands of institutional investors. The top three institutional holders of PPBT stocks are: ARMISTICE CAPITAL, LLC with ownership of 1.36 million shares, which is approximately 5.2352%. KINGSWOOD WEALTH ADVISORS, LLC, holding 0.21 million shares of the stock with an approximate value of $$84680.0 in PPBT stocks shares; and KINGSWOOD WEALTH ADVISORS, LLC, currently with $$10221.0 in PPBT stock with ownership which is approximately 0.0949%.
